Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124289912 | 12428991 | 2 | F | 20151112 | 20160718 | 20160602 | 20160729 | EXP | BE-CELGENEUS-BEL-2015115010 | CELGENE | 72.00 | YR | M | Y | 70.00000 | KG | 20160729 | OT | BE | BE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124289912 | 12428991 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 170.38 | MG | INJECTION FOR INFUSION | ||||||
124289912 | 12428991 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 170.38 | MG | INJECTION FOR INFUSION | ||||||
124289912 | 12428991 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | Y | 0 | 1363.06 | MG | INJECTION FOR INFUSION | ||||||
124289912 | 12428991 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | Y | 0 | 1363.06 | MG | INJECTION FOR INFUSION | ||||||
124289912 | 12428991 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
124289912 | 12428991 | 6 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
124289912 | 12428991 | 7 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | UNKNOWN | QD | |||||||
124289912 | 12428991 | 8 | C | clexane | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | 100 | MG | UNKNOWN | QD | |||||||
124289912 | 12428991 | 9 | C | litican | ALIZAPRIDE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | UNKNOWN | ||||||||
124289912 | 12428991 | 10 | C | litican | ALIZAPRIDE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | UNKNOWN | ||||||||
124289912 | 12428991 | 11 | C | perio-aid | 2 | Oral | 1 UNIT | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124289912 | 12428991 | 1 | Pancreatic carcinoma |
124289912 | 12428991 | 3 | Pancreatic carcinoma |
124289912 | 12428991 | 5 | Hypercholesterolaemia |
124289912 | 12428991 | 6 | Insomnia |
124289912 | 12428991 | 7 | Insomnia |
124289912 | 12428991 | 8 | Thrombosis |
124289912 | 12428991 | 9 | Nausea |
124289912 | 12428991 | 11 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124289912 | 12428991 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124289912 | 12428991 | Anaemia | |
124289912 | 12428991 | Decreased appetite | |
124289912 | 12428991 | Diarrhoea | |
124289912 | 12428991 | Fatigue | |
124289912 | 12428991 | Hypokalaemia | |
124289912 | 12428991 | Hypomagnesaemia | |
124289912 | 12428991 | Nausea | |
124289912 | 12428991 | Pyrexia | |
124289912 | 12428991 | Vomiting | |
124289912 | 12428991 | Weight decreased | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124289912 | 12428991 | 1 | 20150922 | 20151201 | 0 | |
124289912 | 12428991 | 2 | 20151222 | 0 | ||
124289912 | 12428991 | 3 | 20150922 | 20151201 | 0 | |
124289912 | 12428991 | 4 | 20150922 | 0 | ||
124289912 | 12428991 | 5 | 2010 | 0 | ||
124289912 | 12428991 | 6 | 201509 | 0 | ||
124289912 | 12428991 | 7 | 201509 | 0 | ||
124289912 | 12428991 | 8 | 20150921 | 0 | ||
124289912 | 12428991 | 9 | 20151006 | 0 | ||
124289912 | 12428991 | 10 | 20151201 | 0 | ||
124289912 | 12428991 | 11 | 20151020 | 0 |